It is currently Sat Oct 25, 2014 12:13 am

News News of Tecfidera (BG-12, dimethyl fumarate)

Site map of Tecfidera (BG-12, dimethyl fumarate) » Forum : Tecfidera (BG-12, dimethyl fumarate)

Discuss Tecfidera (BG-12, dimethyl fumarate) as an oral treatment for multiple sclerosis.

Oral treatment for MS, Tecfidera, approved for use in Canada

A new oral treatment for those living with multiple sclerosis has been approved for use in Canada.

Tecfidera is an oral medication recently approved by Health Canada..... Read More - http://www.ms-uk.org/index.cfm/BG12
Read more : Oral treatment for MS, Tecfidera, approved for use in Canada | Views : 908 | Replies : 2


Ingredient in new MS drug, Tecfidera, linked to PML

The active ingredient in a drug that’s expected to become a popular treatment for multiple sclerosis has been linked to four European cases of a rare but sometimes fatal brain disease called progressive multifocal leukoencephalopathy (PML)........ Read More - http://www.ms-uk.org/index.cfm/BG12
Read more : Ingredient in new MS drug, Tecfidera, linked to PML | Views : 2076 | Replies : 4


Cost Dimethyl fumarate (Techfiodra).

$ :confused: :confused: 50K a year! http://pipeline.corante.com/archives/20 ... _price.php. I plan to go on it anyway. The $10 program they will start sounds good. This site says you can get a 3 year supply for $104 of cheaper with out docs script. Techfedora has been around for a long time. Just curious. ...
Read more : Cost Dimethyl fumarate (Techfiodra). | Views : 2264 | Replies : 6


Tecfidera efficacy & potential toxicity

I just finished reading the prescribing information for Tecfidera. Of the two studies cited, one did not show a significant effect on disease progression.

Biogen wrote:Tecfidera had a statistically significant effect on all of the relapse and MRI endpoints described above. There was no statistically significant effect on disability progression. The Tecfidera 240 mg three times daily dose resulted in no additional benefit over the Tecfidera 240 mg twice daily dose.

· · · · · ...
Read more : Tecfidera efficacy & potential toxicity | Views : 3461 | Replies : 7


Tecfidera - a mistake to make it oral?

Wow, maybe the newly released oral MS med Tecfidera (previously BG-12) should have been an injection med instead!! :-D Am anxious to hear how debilitating the nausea, vomiting & diarrhea side effects are. Apparently they're enough for patients to stop the med.

Although an irritable digestive system might be characterized as "minor" and not very life-threatening, dealing with constant and/or severe stomach flu-type symptoms could easily ...
Read more : Tecfidera - a mistake to make it oral? | Views : 7217 | Replies : 24


FDA approves new oral multiple sclerosis drug, Tecfidera

The Food and Drug Administration said Wednesday it approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.

The twice-a-day capsules, called Tecfidera, offer a new option for multiple sclerosis, a debilitating disease in which the body attacks its own nervous system. Cambridge, Mass.-based Biogen Idec already sells two other drugs for the disease, but both require injections.......Read More - http://www.ms-uk.org/index.cfm/BG12
Read more : FDA approves new oral multiple sclerosis drug, Tecfidera | Views : 1409 | Replies : 0


New to ThisIsMS BG12 User

I am a 54 year old female with RRMS. I was dx'd in 2000 but had MS for about 6 years before that. I didn't use any meds until the BG12 trial which I started in January of 2008 for me so I have been on the correct dose since the start. It was measured against a higher dose, placebo and copaxone.

Since it received FDA approval today, I can now gladly answer any questions ...
Read more : New to ThisIsMS BG12 User | Views : 2865 | Replies : 22




Aubagio (teriflunomide) and Tecfidera (BG-12) move closer

Aubagio (teriflunomide) and Tecfidera (BG-12) move closer to European approval

The Committee for Medicinal Products for Human Use (CHMP) issued positive opinions on two new MS therapies. Recommending the granting of a marketing authorisation for the medicinal product Tecfidera 120 mg and 240 mg, gastro-resistant hard capsules, intended for the treatment of adult patients with relapsing remitting multiple sclerosis and Aubagio 14 mg film-coated tablet intended for the treatment of multiple sclerosis.... Read More - ...
Read more : Aubagio (teriflunomide) and Tecfidera (BG-12) move closer | Views : 1007 | Replies : 0


Patent granted for MS drug Tecfidera (BG-12) until 2028

Patent granted for Multiple Sclerosis drug Tecfidera (BG-12) until 2028

Biogen Idec Inc announces it has been granted a new patent that will help protect the market exclusivity of its multiple sclerosis drug Tecfidera (BG-12) until 2028.

The new patent covers the dosing regimen for Tecfidera of 480 milligrams a day....Read more - http://www.ms-uk.org/index.cfm/BG12
Read more : Patent granted for MS drug Tecfidera (BG-12) until 2028 | Views : 1280 | Replies : 0


 

Login  •  Register


Statistics

Total posts 220860 • Total topics 22892 • Total members 14455


Contact us | Terms of Service